Published in Adv Ther on October 23, 2015
Recommendations for the management of idiopathic pulmonary fibrosis in South Africa: a position statement of the South African Thoracic Society. J Thorac Dis (2016) 0.76
Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia. BMC Pulm Med (2017) 0.75
Role of pirfenidone in the management of pulmonary fibrosis. Ther Clin Risk Manag (2017) 0.75
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
Consensus methods for medical and health services research. BMJ (1995) 17.94
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med (2000) 12.71
Consensus development methods, and their use in clinical guideline development. Health Technol Assess (1998) 11.56
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2006) 5.86
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2005) 5.83
Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1998) 4.88
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
The Delphi technique: a critique. J Adv Nurs (1987) 3.91
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med (2011) 3.85
Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov (2010) 3.20
A compilation of strategies for implementing clinical innovations in health and mental health. Med Care Res Rev (2011) 2.87
The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax (2006) 2.59
Idiopathic pulmonary fibrosis. Orphanet J Rare Dis (2008) 2.34
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J (2010) 2.17
Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc (1998) 2.04
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest (1993) 1.67
Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J Am Geriatr Soc (2011) 1.56
ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J (2002) 1.52
Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med (2010) 1.11
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials. Respir Res (2013) 1.10
Idiopathic pulmonary fibrosis: natural history and prognosis. Clin Chest Med (2006) 1.06
Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. Can Respir J (2004) 1.05
Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur J Intern Med (2008) 0.99
Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians. Respir Med (2007) 0.98
Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir Med (2011) 0.96
Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis. Intern Med (2012) 0.96
International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia (2011) 0.95
Neutrophil adsorption by polymyxin B-immobilized fiber column for acute exacerbation in patients with interstitial pneumonia: a pilot study. Blood Purif (2010) 0.93
Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis. Intern Med (2010) 0.92
Messages to use in population-level campaigns to reduce mental health-related stigma: consensus development study. Epidemiol Psichiatr Soc (2010) 0.85
Idiopathic pulmonary fibrosis: current trends in management. Clin Chest Med (2004) 0.84
Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis. Intern Med (2011) 0.84
Developing evidence-based standards for diagnosis and management of lower urinary tract or pelvic floor dysfunction. Neurourol Urodyn (2012) 0.84
Acute exacerbation of idiopathic pulmonary fibrosis. Clin Chest Med (2012) 0.82
Development and validation of the ACE tool: assessing medical trainees' competency in evidence based medicine. BMC Med Educ (2014) 0.80
Management of idiopathic pulmonary fibrosis. Clin Chest Med (2011) 0.80
Idiopathic pulmonary fibrosis: phenotypes and comorbidities. Clin Chest Med (2012) 0.79